News
Please, enter cell line, author or any other phrase or word you would like to search for.
Interim Report 3 (2020-11-01 – 2021-01-31)
The second wave of the pandemic restricted sales during the 3rd quarter. However, the situation has improved significantly since late January.
PHI Secure Working Capital Until 2023
PHI has received a second loan commitment of 20 MSEK. In total, the company has received loan commitments of 35 MSEK that are expected to secure the company’s working capital until 2023.
Interim Report 2 (2020-08-01 – 2020-10-31)
The relaxed COVID-19 restrictions during the 2nd quarter led to a noticeable increase in sales.
Interim Report 1 (2020-05-01 – 2020-07-31)
The global COVID-19 restrictions have dramatically affected customers’ ability to receive us for onsite demonstrations, installations and customer training. Despite this, several HoloMonitor units have been delivered since the beginning of the fiscal year in May.
PHI improves search engine ranking by enhancing website performance significantly
PHI improves website ranking by enhancing website performance significantly.
PHI granted patent on synthetic antibodies in the U.S.
PHI announces today that the Company has been granted a patent on synthetic antibodies from the United States Patent and Trademark Office.
Year-end Report 2019/20
To emerge stronger from the pandemic than entering it, we have for the time being focused our resources on reducing sales cost, improving our market visibility and expanding the HoloMonitor product line.
National Institute on Aging and PHI sign collaboration agreement
The National Institute on Aging and PHI recently entered a collaboration agreement, aiming to develop an add-on fluorescent module for PHI’s HoloMonitor imaging cytometer.
PHI secure working capital until 2022
To bridge and adapt to the consequences of the COVID-19 pandemic, PHI has received a binding credit facility of 15 MSEK.
Interim Report 3 2019/20
With permanent staff on the ground in the US, we will be able to prepare, train and support a US sales organization much more efficiently than what was previously achievable.